VivoSeq
Infectious Disease

Skin Disease Caused by Bacterial Infection

4

Pipeline Programs

0

Active Trials

3

Companies Involved

Skin Disease Caused by Bacterial Infection is an early-stage landscape with 4 programs across 3 companies. The most active players are Prism Pharmaceuticals, AbbVie, Bayer. 3 therapies are approved.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

N/A

Attrition Rate

N/A

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)